Chimeric Natural Killer Receptor Universal T-cells (CNK-UT) Clinical Trials
3 recruitingBiologic
Phase 13
Showing 1–3 of 3 trials
Recruiting
Phase 1
Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma
Neuroblastoma, Recurrent, Refractory
Nanjing Children's Hospital12 enrolled2 locationsNCT06751134
Recruiting
Phase 1
Universal CNK-UT Therapy for Refractory aGVHD
First Affiliated Hospital of Zhejiang University23 enrolled2 locationsNCT06750133
Recruiting
Phase 1
Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD
Graft vs Host Disease
Fujian Medical University17 enrolled1 locationNCT06568328